Evoq Remedies Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	0.05	2.14	1.23	1.54	30.94
Cash & Short-Term Investments	0.05	2.14	1.23	1.54	30.94
Cash Growth	-97.57%	73.50%	-19.66%	-95.04%	9179.27%
Accounts Receivable	38.55	86.17	17.43	172.16	253.98
Receivables	375.08	365.28	332.78	250.85	291.33
Inventory	16.71	22.19	31.25	20.32	7.84
Other Current Assets	125.83	108.25	3.21	76.19	3.2
Total Current Assets	517.68	497.86	368.47	348.89	333.31
Property, Plant & Equipment	1.72	2.23	0.14	0.09	-
Other Long-Term Assets	-	-	-	0	-
Total Assets	519.4	500.09	368.61	348.99	333.31
Accounts Payable	7.64	34.97	32.83	-5.37	12.09
Accrued Expenses	-	3.2	0.1	0.12	4.31
Short-Term Debt	0.73	-	42.38	95.76	81.58
Current Income Taxes Payable	6.24	7.2	8.14	8.67	3.67
Other Current Liabilities	61.83	9.37	32.78	1.95	-
Total Current Liabilities	76.44	54.73	116.23	101.13	101.65
Total Liabilities	76.44	54.73	116.23	101.13	101.65
Common Stock	249	249	136	136	136
Additional Paid-In Capital	-	163.52	84.42	84.42	84.42
Retained Earnings	-	32.84	31.96	27.44	11.24
Comprehensive Income & Other	193.96	-	-	-	-
Shareholders' Equity	442.96	445.36	252.38	247.86	231.66
Total Liabilities & Equity	519.4	500.09	368.61	348.99	333.31
Total Debt	0.73	-	42.38	95.76	81.58
Net Cash (Debt)	-0.68	2.14	-41.15	-94.23	-50.64
Net Cash Per Share	-0.03	0.09	-3.03	-6.93	-5.06
Filing Date Shares Outstanding	20.83	24.9	13.6	13.6	13.6
Total Common Shares Outstanding	20.83	24.9	13.6	13.6	13.6
Working Capital	441.24	443.13	252.24	247.76	231.66
Book Value Per Share	21.27	17.89	18.56	18.22	17.03
Tangible Book Value	442.96	445.36	252.38	247.86	231.66
Tangible Book Value Per Share	21.27	17.89	18.56	18.22	17.03
Machinery	-	-	-	0.13	-